click below
click below
Normal Size Small Size show me how
Musculoskeletal
| Brand | Generic | Category | Indications | Essential Knowledge |
|---|---|---|---|---|
| Zanaflex | tizanidine (PO) | Alpha2 agonist | Spasticity | Key Side Effects: drowsiness, hypotension, dizziness, xerostomia, weakness |
| Plaquenil | hydroxychloroquine (PO) | Aminoquinolone | RA, SLE, malaria | Key Side Effects: retinal toxicity, rash, diarrhea Other Notes: long-term use has been associated with cardiomyopathy, bone marrow suppression, QT prolongation, and neuromuscular effects (i.e., myopathy, palsies, and progressive weakness) |
| Voltaren Gel (OTC) | diclofenac (topical) | NSAID | OA | Key Side Effects: pruritus, rash |
| Voltaren | diclofenac (PO) | NSAID | OA, RA, acute pain | Key Side Effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| Motrin, Advil (all OTC) | ibuprofen (PO) | NSAID | OA, RA, acute pain | Key Side Effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| Mobic | meloxicam (PO) | NSAID | OA, RA, acute pain | Key Side Effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| Indocin | indomethacin (PO) | NSAID | OA, RA, acute pain, gout | Key Side Effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| Naprosyn, Anaprox, Aleve (all OTC) | naproxen (PO) | NSAID | OA, RA, acute pain, gout | Key Side Effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| Toradol | keterolac (PO, IV) | NSAID | Pain | Key Side Effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea BW: may increase the risk of serious/potentially fatal cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious GI adverse events including ulceration, bleeding, perforation US Boxed Warning (only for ketorolac): indicated for short term use (≤ 5 days) Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| Celebrex | celecoxib (PO) | NSAID, COX-2 selective | OA, RA, acute pain | Key Side Effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events, MI, and stroke; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis) |
| Flexeril, Amrix, Fexmid | cyclobenzaprine (PO) | Skeletal muscle relaxant | Muscle spasm | Key Side Effects: drowsiness, dizziness, xerostomia, fatigue Other Notes: use may cause prolonged cardiac arrhythmias, and tachycardia; CI within 14 days of MAOI therapy |
| --- | baclofen (PO) | Skeletal muscle relaxant | Spasticity | Key Side Effects: drowsiness |
| Robaxin | methocarbamol (PO) | Skeletal muscle relaxant | Muscle spasm | Key Side Effects: drowsiness |
| Transdermal: Lidoderm (OTC) IV: Xylocaine | lidocaine (transdermal, IV) | Transdermal: topical analgesic IV: antiarrhythmic | Transdermal: pain IV: ventricular arrhythmias | Key Side Effects (transdermal): dermatitis, erythema, urticaria, skin depigmentation, skin edema Key Side Effects (IV): bradycardia Other Notes: patch may remain in place for up to 12 hours in any 24-hour period, patch may be cut |
| Colcrys | colchicine (PO) | Antigout agent | Gout | Key Side Effects: diarrhea, nausea, vomiting, bone marrow suppression, myopathy (including rhabdomyolysis) |
| Zyloprim | allopurinol (PO) | Xanthine oxidase inhibitor | Gout | Key Side Effects: diarrhea, nausea, rash, leukopenia, thrombocytopenia Other Notes: rare association with severe (and potentially fatal) allopurinol hypersensitivity syndrome (risk highest in certain Asian populations) |
| Anectine | succinylcholine (IV) | Depolarizing neuromuscular blocking agent | Neuromuscular blockade for intubation for procedures | Key Side Effects: hyperkalemia, myalgia, malignant hyperthermia (rare) US Boxed Warning: acute rhabdomyolysis and hyperkalemia leading to cardiac arrest and death in pediatric patients with undiagnosed skeletal muscle disease |
| Enbrel | etanercept (SQ) | Anti-tumor necrosis factor alpha inhibitor | RA | Key Side Effects: infection, injection site reaction, headache, nausea US Boxed Warning: serious infections, malignancies such as lymphoma |
| Humira | adalimumab (SQ) | Anti-tumor necrosis factor alpha inhibitor | RA, Crohn's Disease, Ulcerative Colitis | Key Side Effects: infection, injection site reaction, headache, nausea US Boxed Warning: serious infections, malignancies such as lymphoma |